4//SEC Filing
BORKOWSKI EDWARD 4
Accession 0001415889-20-001398
CIK 0001604191other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 5:10 PM ET
Size
8.3 KB
Accession
0001415889-20-001398
Insider Transaction Report
Form 4
BORKOWSKI EDWARD
Director
Transactions
- Award
9.0% Senior Convertible Promissory Note
2020-06-01$100000.00/shExercise: $1.07From: 2019-12-20Exp: 2020-09-20→ Common Stock (93,458 underlying) - Disposition to Issuer
9.0% Senior Convertible Promissory Note
2020-06-01$100000.00/sh→ 0 totalExercise: $0.97From: 2019-12-20Exp: 2020-09-20→ Common Stock (103,093 underlying)
Footnotes (3)
- [F1]On June 1, 2020, AzurRx Biopharma, Inc. (the "Company") and Edward Borkowski amended the Senior Convertible Promissory Note (the "Note") previously issued on December 20, 2019 to increase the conversion price from $0.97 per share to $1.07 per share.
- [F2]Represents the number of shares of the Company's common stock, par value $0.001 per share ("Common Stock") issuable upon conversion of the principal amount of the Note at the original conversion price of $0.97 per share.
- [F3]Represents the number of shares of Common Stock issuable upon conversion of the principal amount of the Note at the amended conversion price of $1.07 per share.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001197542
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 5:10 PM ET
- Size
- 8.3 KB